# Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

> **NCT00030082** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Liver Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** isolated perfusion
- **DRUG:** melphalan

## Key facts

- **NCT ID:** NCT00030082
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030082, "Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00030082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*